- Active not recruitingPHASE3
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
This study is testing a new medicine, Belumosudil, alongside standard steroids for people aged 12 and over newly diagnosed with chronic Graft-versus-Host Disease (cGVHD). We want to see if this combination works better to manage the condition.
For: Chronic Graft Versus Host DiseaseUnited States · Argentina · Australia - RecruitingPHASE2
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
This study is looking at a new medicine called Belumosudil for children aged 1 to 18 with chronic graft versus host disease (cGVHD). We want to see how well it works and if it's safe for those who haven't responded to other treatments.
For: Chronic Graft Versus Host DiseaseUnited States · Belgium · Canada